Cayman Chemical Immuno-Oncology Screening Library

Tuesday, 05 March, 2024 | Supplied by: Sapphire Bioscience


Cayman Chemical’s Immuno-Oncology Screening Library consists of two plates and contains more than 90 cancer and immunology-associated compounds in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO.

The library includes a variety of immuno-oncology target modulators, including but not limited to: adenosine, CCR, CXCR and TLR agonists and antagonists; BTK, PI3K, VEGFR and BRAF inhibitors; PD-1/PD-L1 interaction inhibitors; and HDAC inhibitors. Panels are routinely re-evaluated to include new catalogue introductions as the research evolves.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...

Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration

The antibodies are specific to CTC surface markers to enable the sensitive and specific...

Microbiologics UV-BioTAG QC microorganisms for quality control testing

UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd